Recombinant Cyclin Dependent Kinase Inhibitor 2A (CDKN2A) Homo sapiens (Human) Recombinant protein

P16; ARF; CDK4I; CMM2; INK4; INK4a; MLM; MTS1; TP16; P14; P14ARF; P16INK4a; P19; Melanoma P16; Cyclin-dependent kinase 4 inhibitor A; Multiple tumor suppressor 1

  • UOM
    1. 10µg
    2. 50µg
    3. 200µg
    4. 1mg
    5. 5mg
  • FOB US$ 172.00 US$ 430.00 US$ 860.00 US$ 2,580.00 US$ 6,450.00
  • Quantity
    In stock
Add to Cart Distributors Free trial
  • Source Prokaryotic expression, Host E.coli
  • Endotoxin Level<1.0EU per 1µg (determined by the LAL method)
  • Subcellular LocationCytoplasm. Nucleus
  • Molecular Mass 19.7kDa, Accurate n/a(Analysis of differences refer to the manual)
  • Residues & TagsSer8~Asp156 (Accession # P42771) with N-terminal His Tag
  • Buffer FormulationPBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
  • Traits Freeze-dried powder, Purity > 95%
  • Isoelectric Point6.4
Share your citation Upload your experimental result Review Leave a message

Share a new citation as an author

Upload your experimental result


Please attach serial No. on instruction manual

Contact us

Please fill in the blank.

E-mail address*
Verification code* CheckCode
  • Recombinant Cyclin Dependent Kinase Inhibitor 2A (CDKN2A) Packages (Simulation)
  • Recombinant Cyclin Dependent Kinase Inhibitor 2A (CDKN2A) Packages (Simulation)
  • RPA794Hu01.jpg SDS-PAGE
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered



Reconstitute in PBS or others.


Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.


The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.


  • Comparison of Selected Protein Levels in Tumour and Surgical Margin in a Group of Patients with Oral Cavity Cancerpubmed:28421310

Recommend products